SXTP ($SXTP) Insider Trading & Smart Money Activity

SXTP · Biotechnology · Latest filing Jun 12, 2026

$SXTP has 2 insider trades on file. In the last 12 months on the open market, 1 insider bought ($20.29K) and no insider sold, net +$20.29K.

Insider buyers (12 mo)
1
Insider sellers (12 mo)
0
Net insider $ (12 mo)
+$20.29K
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

SXTP insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 2 · $20.29K 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All SXTP insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Geoffrey DowPresident and CEO Buy (Open-market buy) 7.35K sh $10.14K +24.3%+6.6% —
Insider Geoffrey DowPresident and CEO Buy (Open-market buy) 7.35K sh $10.14K +24.3%+6.6% Read

1W / 1M / 6M = how SXTP moved from the trade or filing date.

Insider trading in SXTP: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Geoffrey Dow President and CEO 2 +$20.29K Jun 12, 2026

Frequently asked questions

Are SXTP insiders buying or selling?

Over the last 12 months 1 insider made 2 open-market purchases worth $20.29K and 0 insiders made 0 open-market sales worth $0, a net +$20.29K.

What is the latest insider trade in SXTP?

Geoffrey Dow, President and CEO filed a buy (open-market buy) of 7.35K sh worth $10.14K on Jun 12, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text